Skip to main content

Adam Bress, Pharm.D., M.S.

Languages spoken: English

Academic Information

Departments: Population Health Sciences - Associate Professor

Divisions: Health System Innovation and Research

Academic Office Information

Research Interests

  • Health Disparities
  • Pharmacoepidemiology
  • Pharmacogenetics
  • Cardiovascular Disease Prevention and Treatment
  • Hypertension
  • Heart Failure

Dr. Bress is currently an Associate Professor of Population Health Sciences with Tenure in the Division of Health System Innovation and Research and an Investigator at the VA Salt Lake City Health Care System. He also serves as the Vice Chair of Reserach for the Department of Population Health Sciences.

Dr. Bress is a formally-trained cardiovascular clinical pharmacist and population scientist. His research is focused on the prevention and treatment of cardiovascular disease, optimizing medication use, and reducing health disparities. He is particularly interested in studying antihypertensive medication use, responses, and outcomes to help patients and providers, as well as health systems, payers, governments, and population health managers make better decisions about how to treat and control high blood pressure. Dr. Bress's research has been published as first author in the New England Journal of Medicine, The Journal of the American College of Cardiology, and Circulation and has been covered in TIME Magazine, The New York Times, and CBS radio. He is also interested in genetic ancestry and racial/ethnic differences in antihypertensive medication responses. He was elected as the 2020 National Academy of Medicine Fellow in Pharmacy. As a NAM Fellow, he currently serves on the National Academies’ Roundtable on the Promotion of Health Equity.

Dr. Bress is a former NHLBI K01 awardee (K01HL133468) and is currently NIH-funded as a Principal Investigator by an NHLBI R01 (R01HL139837) and two NIA R01s (R01AG06580501 and R01AG074989). He also received grant support from the biomedical industry as PI for investigator-initiated research projects focused on cardiovascular pharmacoepidemiology.

Dr. Bress has established collaborations with a multi-disciplinary team of investigators in hypertension, cardiology, health services research, epidemiology, and pharmacogenetics at the University of Utah and around the country. He is an active member of the hypertension working groups for two ongoing NIH-funded cohort studies including the Jackson Heart Study (JHS), the Coronary Artery Risk Development in Young Adults (CARDIA) Study, and the Women's Health Initiative (WHI). He is also an active member of the Systolic Blood Pressure Intervention Trial (SPRINT) Research Group.

Dr. Bress received his Doctor of Pharmacy degree from the University of Maryland, and his Masters of Science in Clinical and Translational Science from the University of Illinois at Chicago School of Public Health with a focus on epidemiology. He completed his residency in pharmacy practice at Yale-New Haven Hospital and Cardiology at the University of Illinois at Chicago. He subsequently completed his post-doctoral research fellowship in cardiovascular pharmacogenomics at the University of Illinois at Chicago.

Research Statement

I am a cardiovascular clinical pharmacist with training in epidemiology and pharmacogenetics. We focus on disparities in prevention and treatment of cardiovascular disease with a focus on hypertension and antihypertensive medication use. Using pharmacoepidemiology and pharmacogenetics, we try to better understand causes of racial differences in medication responses and outcomes. We apply these findings to understand the population-level impact, generalizability, and cost-effectiveness in diverse groups.

Education History

Graduate Training University of Illinois at Chicago School of Public Health
Clinical and Translational Science
Research Fellow University of Illinois at Chicago
Cardiovascular Pharmacogenomics
Research Fellow
Residency University of Illinois at Chicago
Residency Yale-New Haven Hospital
Pharmacy Practice
Doctoral Training University of Maryland

Global Impact


Description Country
Featured Faculty, "Optimizing antihypertensive treatment in 2017: Lessons using pharmacoepidemiology and pharmacoeconomics", China Heart Congress, Beijing, China, August 10th, 2017 China